SPP1 and endometriosis: To further demonstrate the OPN/p-PI3K/uPA pathway performances vital function in endometriosis, we used 50 μM of ly294002 and 4 μM of SF1670 after 12-h and 24-h treatment to inhibit and activate the p-PI3K pathway respectively.